1-2 of 2
Michael Jain
Close
Sort by
Journal Articles

Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma

Clinical Trials & Observations
Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C. Peres, Melissa Alsina, Christina Bachmeier, Brandon J. Blue, Jason Brayer, Sanjay Chandrasekhar, Ariel Grajales Cruz, Gabe De Avila, Hany Elmariah, Rawan Faramand, Ciara Freeman, Michael Jain, Sushmita Khadka, Farhad Khimani, Hien Liu, Taiga Nishihori, Laura B. Oswald, Omar A. Castaneda Puglianini, Kenneth H. Shain, Eric Smith, Rachid C. Baz, Frederick L. Locke, Guilherme H. Oliveira, Mohammed Alomar, Doris K. Hansen
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4247–4257.
https://doi.org/10.1182/bloodadvances.2023009766
Published: 2023
Journal Articles

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Christopher K. Rushton, Sarah E. Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, Nicole Thomas, Laura K. Hilton, Neil Michaud, Scott Daigle, Jordan Davidson, Kevin Bushell, Stephen Yu, Ryan N. Rys, Michael Jain, Lois Shepherd, Marco A. Marra, John Kuruvilla, Michael Crump, Koren Mann, Sarit Assouline, Joseph M. Connors, Christian Steidl, Mark S. Cragg, David W. Scott, Nathalie A. Johnson, Ryan D. Morin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2886–2898.
https://doi.org/10.1182/bloodadvances.2020001696
Published: 2020
Includes: Supplemental data